Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas

PURPOSE: Glioblastoma (GBM) remains an incurable disease despite extensive treatment with surgical resection, irradiation, and temozolomide. In line with many other forms of aggressive cancers, GBM is currently under consideration as a target for immunotherapy. However, GBM tends to be nonimmunogeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Nesseler, Jean Philippe, Schaue, Dorthe, McBride, William H., Lee, Mi-Heon, Kaprealian, Tania, Niclou, Simone P., Nickers, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Central Nervous System
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460102/
https://www.ncbi.nlm.nih.gov/pubmed/31011672
http://dx.doi.org/10.1016/j.adro.2018.11.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460102/
https://www.ncbi.nlm.nih.gov/pubmed/31011672
http://dx.doi.org/10.1016/j.adro.2018.11.005

Ejemplares similares